Q-linea AB (publ) (QLINEA.ST)

SEK 0.97

(-1.62%)

Long Term Debt Summary of Q-linea AB (publ)

  • Q-linea AB (publ)'s latest annual long term debt in 2023 was 12.9 Million SEK , down -12.88% from previous year.
  • Q-linea AB (publ)'s latest quarterly long term debt in 2024 Q2 was 8.68 Million SEK , down 0.0% from previous quarter.
  • Q-linea AB (publ) reported annual long term debt of 14.81 Million SEK in 2022, up 11.92% from previous year.
  • Q-linea AB (publ) reported annual long term debt of 13.23 Million SEK in 2021, up 16653.16% from previous year.
  • Q-linea AB (publ) reported quarterly long term debt of 9.61 Million SEK for 2024 Q1, down 0.0% from previous quarter.
  • Q-linea AB (publ) reported quarterly long term debt of 17.92 Million SEK for 2023 Q1, up 21.03% from previous quarter.

Annual Long Term Debt Chart of Q-linea AB (publ) (2023 - 2015)

Historical Annual Long Term Debt of Q-linea AB (publ) (2023 - 2015)

Year Long Term Debt Long Term Debt Growth
2023 12.9 Million SEK -12.88%
2022 14.81 Million SEK 11.92%
2021 13.23 Million SEK 16653.16%
2020 79 Thousand SEK -76.13%
2019 331 Thousand SEK -53.31%
2018 709 Thousand SEK 0.0%
2017 - SEK 0.0%
2016 - SEK -100.0%
2015 102 Thousand SEK 0.0%

Peer Long Term Debt Comparison of Q-linea AB (publ)

Name Long Term Debt Long Term Debt Difference
AddLife AB (publ) 2.53 Billion SEK 99.492%
Biotage AB (publ) 150 Million SEK 91.397%
Bonesupport Holding AB (publ) 13.22 Million SEK 2.398%
Doxa AB (publ) 3.6 Million SEK -258.472%
Elekta AB (publ) 4.8 Billion SEK 99.732%
iZafe Group AB (publ) 279 Thousand SEK -4525.448%
Ortivus AB (publ) 3.57 Million SEK -261.08%
Ortivus AB (publ) 3.57 Million SEK -261.08%
S2Medical AB (publ) - SEK -Infinity%
Synsam AB (publ) 2.02 Billion SEK 99.364%